Vimarsana
Biggest News Aggregation in the World

Page 46 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Query Get Today - Breaking & Trending Today

Oral baricitinib bests placebo in severe alopecia areata treatment - Vimarsana News

Oral baricitinib bests placebo in severe alopecia areata treatment

A 4 mg dose of baricitinib was associated with significant improvement compared with placebo in alopecia areata disease severity, according to a study. “Alopecia areata is an autoimmune disorder marked by disfiguring, nonscarring hair loss, and there are no therapies approved by the FDA for treatment of the disease,” Brett King, MD, PhD, of the Yale School of Medicine, told

Source: healio.com
New data show cardiovascular benefits of anemia drug for patients with CKD, ESKD - Vimarsana News

New data show cardiovascular benefits of anemia drug for patients with CKD, ESKD

New research presented during the late-breaking trials program at the National Kidney Foundation Spring Clinical Meetings showed the anemia drug daprodustat has cardiovascular benefits comparable to erythropoiesis-stimulating agents.

Source: healio.com
Q&A: Issues in pediatric blood lead testing - Vimarsana News

Q&A: Issues in pediatric blood lead testing

A recent CDC revision to the reference value used to identify children with high levels of lead in their blood doubled the estimated number of children who should be referred for follow-up, per guidelines, a pair of experts noted recently.

Source: healio.com
Cats and dogs may pass antibiotic-resistant bacteria to their owners - Vimarsana News

Cats and dogs may pass antibiotic-resistant bacteria to their owners

Cats and dogs could be passing antibiotic-resistant bacteria and resistance genes to their owners, according to study findings that will be presented this month at the European Congress of Clinical Microbiology and Infectious Diseases.

Source: healio.com
Apremilast could lower cardiometabolic risk in psoriasis patients - Vimarsana News

Apremilast could lower cardiometabolic risk in psoriasis patients

BOSTON — Psoriasis patients treated with apremilast saw a reduction in subcutaneous and visceral fat, indicating a possible decline in cardiometabolic risk, according to a presentation at the American Academy of Dermatology Annual Meeting.“We know our patients have an increased risk of obesity, an increased risk of dyslipidemia and an increased risk of diabetes, but on top of that,

Source: healio.com